🔎 Trials Near Me

Dachaigh › Glioma Pontine Intrinsic Sgaoilte › Massachusetts

Sgrùdaidhean clionaigeach Glioma Pontine Intrinsic Sgaoilte ann an Massachusetts

Tha 9 sgrùdaidhean airson Glioma Pontine Intrinsic Sgaoilte a’ lorg phàirtichean aig làraichean ann an Massachusetts.

Bailtean ann an Massachusetts

Teacsa sgrùdaidh oifigeil (Beurla)

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
12 Months – 21 Years · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT04870944

Targeted Pediatric High-Grade Glioma Therapy

  • Dana-Farber Cancer Institute, Boston
A’ fastadhSgrùdadh amharc
12 Months – 39 Years · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Susan Chi, Boston
A’ fastadhÌre 2
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 3 gu 39 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05096481

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1 tràthFàilte do shaor-thoilich fhallain
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT06333899

Combination Therapy for the Treatment of Diffuse Midline Gliomas

  • Dana-Farber Cancer Institute Harvard University, Boston
A’ fastadhÌre 2
Aoisean 2 gu 39 · Gach gnè · Air ùrachadh 26 Ògmh 2026 · NCT05009992

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
12 Months – 39 Years · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1 tràth
Suas gu aois 21 · Gach gnè · Air ùrachadh 18 Màrt 2026 · NCT04655404

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

  • Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston
A’ fastadhÌre 1
12 Months – 18 Years · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT04943848

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.